Lipid-lowering agent: Difference between revisions

(6 intermediate revisions by the same user not shown)

Line 2:

{| class="wikitable sortable" style="width:100%"

|+脂質降下薬（その他）

|-

!一般名

!先発名

!class="unsortable"| 日本

!創薬/開発

!備考

|-

|[[Omega-3 acid ethyl esters/ja]]

|[https://www.takedamed.com/medicine/detail?medicine_id=601 ロトリガ](武田薬品) ([https://pins.japic.or.jp/pdf/newPINS/00060775.pdf PI]) ([https://www.takedamed.com/medicine/detail?medicine_id=601&setpopflage=true IF])

|販売

|[[Takeda Pharmaceutical Company]]

|

|-

|[[Ethyl eicosapentaenoic acid/ja]]

|[https://med.mochida.co.jp/medicaldomain/circulatory/epadel/index.html エパデール](持田製薬) ([https://med.mochida.co.jp/txt/pdf/epa-s_n22.pdf PI]) ([https://med.mochida.co.jp/interview/epas_n22.pdf IF])

|販売

|[[Mochida Pharmaceutical]]

|

|-

|}

'''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'.

@@ Line 2: / Line 2: @@
 <translate>
 <!--T:1-->
+{{Drug List/ja}}
+{{PathNav|Medication|frame=1}}
+{| class="wikitable sortable" style="width:100%"
+|+脂質降下薬（その他）
+|-
+!一般名
+!先発名
+!class="unsortable"| 日本
+!創薬/開発
+!備考
+|-
+|[[Omega-3 acid ethyl esters/ja]]
+|[https://www.takedamed.com/medicine/detail?medicine_id=601 ロトリガ](武田薬品) ([https://pins.japic.or.jp/pdf/newPINS/00060775.pdf PI]) ([https://www.takedamed.com/medicine/detail?medicine_id=601&setpopflage=true IF])
+|販売
+|[[Takeda Pharmaceutical Company]]
+|
+|-
+|[[Ethyl eicosapentaenoic acid/ja]]
+|[https://med.mochida.co.jp/medicaldomain/circulatory/epadel/index.html エパデール](持田製薬) ([https://med.mochida.co.jp/txt/pdf/epa-s_n22.pdf PI]) ([https://med.mochida.co.jp/interview/epas_n22.pdf IF])
+|販売
+|[[Mochida Pharmaceutical]]
+|
+|-
+|}
 '''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'.